We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CRP Level Is Independent Risk Factor for Stroke

By Biotechdaily staff writers
Posted on 04 Jul 2003
A recent study has shown that the level of C-reactive protein (CRP) in the blood is an independent risk factor for stroke regardless of the thickness of carotid artery walls, and that people with thicker artery walls are at greater risk. More...


Investigators at the University of Vermont (Burlington, USA; www.uvm.edu) determined the CRP level in blood samples from 5,417 men and women age 65 or older participating in the US Cardiovascular Health Study, a prospective trial investigating risk factors for cardiovascular disease in the elderly. In addition, each patient was examined by ultrasound to determine the thickness of the walls of the carotid artery.

The results, published June 23, 2003, in the online edition of Circulation, showed that subjects in the highest quartile of CRP levels were 60% percent more likely to have a stroke, compared to those with the lowest CRP levels. People in the second quartile were 19% more likely to have a stroke, while those in the third CRP quartile were 5% more likely to have a stroke than those with the lowest levels. Among people with the thinnest carotid walls, there was no significant association between CRP and stroke, but among those people with thicker carotid walls, there was a significant association between CRP and stroke.

"We found that while C-reactive protein is an independent risk factor for stroke, it is even more closely related to stroke in people with thicker artery walls than in people with thinner walls,” explained senior author Dr. Mary Cushman, an associate professor of medicine at the University of Vermont. "This raises the possibility that higher CRP is associated with more active or unstable plaque that is more likely to rupture and cause a stroke. The findings add to the growing body of evidence that supports using CRP measurements in assessing certain individuals' global cardiovascular disease risk.”



Related Links:
University of Vermont

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Aspiration System
VACUSAFE
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.